Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 PharmaBlock Appoints CTO | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

PharmaBlock Appoints CTO

Dr. Shijie Zhang brings over 20 years of combined experience in medicinal chemistry, process chemistry, and API manufacturing

By: Betsy Louda

, Contract Pharma

PharmaBlock Sciences announced the appointment of Dr. Shijie Zhang as chief technology officer. Shijie joins the company from Agios Pharmaceuticals, Inc., where he was director of Process Chemistry and API Manufacturing, CMC.

Dr. Shijie Zhang brings over 20 years of combined experience in medicinal chemistry, process chemistry, and API manufacturing. Before joining PharmaBlock, he led the CMC API team at Agios for the two FDA-approved therapies (Idhifa®, Tibsovo®), by managing and overseeing API development programs and manufacturing activities spanning from preclinical stage to commercial stage, and preparing API sections of regulatory filing documents, including IND, IMPD, NDA, and briefing documents.

“We are thrilled to welcome Shijie on board, and he is truly a key addition to our leadership team,” said Dr. Minmin Yang, chairman of PharmaBlock. “His unparalleled knowledge and intimate experience in bringing drugs from preclinical stage to commercial makes him the best person to lead our rapidly growing CDMO business, and critical to our future strategies.”

“I am delighted to join PharmaBlock, and I have witnessed its remarkable and rapid growth. With its strong leadership role in building blocks business, and impressive progress in process chemistry capabilities, PharmaBlock has a solid foundation to win in CDMO business,” said Dr. Shijie Zhang, “I look forward to working with the tremendous team, helping fulfill its commitment to accelerating pharmaceutical innovation from research, to development, to commercial.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters